Franklin Genomic Advancements ETF (HELX)
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
$10.01M
Feb 25, 2020
21.63
$1.53
0.00
0.00
0.55%
0.00%
0.00
0.00
0.00
0.00
0.00%
0.00%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
95.27%
Materials Select Sector SPDR Fund
XLB
2.6%
Technology Select Sector SPDR Fund
XLK
1.84%
The Real Estate Select Sector SPDR Fund
XLRE
0.29%
Utilities Select Sector SPDR Fund
XLU
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
ETF Constituents (38)
Medpace Holdings, Inc.
MEDP
5.986%
Regeneron Pharmaceuticals, Inc.
REGN
5.766%
Vertex Pharmaceuticals Incorporated
VRTX
5.439%
Danaher Corporation
DHR
5.123%
Eli Lilly and Company
LLY
4.943%
Krystal Biotech, Inc.
KRYS
4.47%
Natera, Inc.
NTRA
3.645%
Ionis Pharmaceuticals, Inc.
IONS
2.56%
Bruker Corporation
BRKR
2.42%
Corteva, Inc.
CTVA
2.117%
Insmed Incorporated
INSM
2.069%
Charles River Laboratories International, Inc.
CRL
1.887%
United Therapeutics Corporation
UTHR
1.74%
Alnylam Pharmaceuticals, Inc.
ALNY
1.682%
Sarepta Therapeutics, Inc.
SRPT
1.675%
Rocket Pharmaceuticals, Inc.
RCKT
1.574%
Exact Sciences Corporation
EXAS
1.517%
Moderna, Inc.
MRNA
1.313%
Ultragenyx Pharmaceutical Inc.
RARE
1.198%
BridgeBio Pharma, Inc.
BBIO
1.101%
Twist Bioscience Corporation
TWST
1.075%
Laboratory Corporation of America Holdings
LH
1.026%
Bio-Techne Corporation
TECH
0.938%
Voyager Therapeutics, Inc.
VYGR
0.877%
Ligand Pharmaceuticals Incorporated
LGND
0.86%
Neurocrine Biosciences, Inc.
NBIX
0.857%
Beam Therapeutics Inc.
BEAM
0.851%
Intellia Therapeutics, Inc.
NTLA
0.826%
4D Molecular Therapeutics, Inc.
FDMT
0.805%
Avid Bioservices, Inc.
CDMO
0.712%
Repligen Corporation
RGEN
0.556%
Recursion Pharmaceuticals, Inc.
RXRX
0.536%
Bio-Rad Laboratories, Inc.
BIO
0.518%
Avantor, Inc.
AVTR
0.516%
Simulations Plus, Inc.
SLP
0.308%
Veracyte, Inc.
VCYT
0.212%
Dynavax Technologies Corporation
DVAX
0.195%
Alexandria Real Estate Equities, Inc.
ARE
0.153%
Sector weights (11)
Health Care Select Sector SPDR Fund
XLV
95.27%
Materials Select Sector SPDR Fund
XLB
2.6%
Technology Select Sector SPDR Fund
XLK
1.84%
The Real Estate Select Sector SPDR Fund
XLRE
0.29%
Utilities Select Sector SPDR Fund
XLU
0%
Industrial Select Sector SPDR Fund
XLI
0%
Financial Select Sector SPDR Fund
XLF
0%
Energy Select Sector SPDR Fund
XLE
0%
Consumer Staples Select Sector SPDR Fund
XLP
0%
Consumer Discretionary Select Sector SPDR Fund
XLY
0%
Communication Services Select Sector SPDR Fund
XLC
0%
ETF Constituents (38)
Medpace Holdings, Inc.
MEDP
5.986%
Regeneron Pharmaceuticals, Inc.
REGN
5.766%
Vertex Pharmaceuticals Incorporated
VRTX
5.439%
Danaher Corporation
DHR
5.123%
Eli Lilly and Company
LLY
4.943%
Krystal Biotech, Inc.
KRYS
4.47%
Natera, Inc.
NTRA
3.645%
Ionis Pharmaceuticals, Inc.
IONS
2.56%
Bruker Corporation
BRKR
2.42%
Corteva, Inc.
CTVA
2.117%
Insmed Incorporated
INSM
2.069%
Charles River Laboratories International, Inc.
CRL
1.887%
United Therapeutics Corporation
UTHR
1.74%
Alnylam Pharmaceuticals, Inc.
ALNY
1.682%
Sarepta Therapeutics, Inc.
SRPT
1.675%
Rocket Pharmaceuticals, Inc.
RCKT
1.574%
Exact Sciences Corporation
EXAS
1.517%
Moderna, Inc.
MRNA
1.313%
Ultragenyx Pharmaceutical Inc.
RARE
1.198%
BridgeBio Pharma, Inc.
BBIO
1.101%
Twist Bioscience Corporation
TWST
1.075%
Laboratory Corporation of America Holdings
LH
1.026%
Bio-Techne Corporation
TECH
0.938%
Voyager Therapeutics, Inc.
VYGR
0.877%
Ligand Pharmaceuticals Incorporated
LGND
0.86%
Neurocrine Biosciences, Inc.
NBIX
0.857%
Beam Therapeutics Inc.
BEAM
0.851%
Intellia Therapeutics, Inc.
NTLA
0.826%
4D Molecular Therapeutics, Inc.
FDMT
0.805%
Avid Bioservices, Inc.
CDMO
0.712%
Repligen Corporation
RGEN
0.556%
Recursion Pharmaceuticals, Inc.
RXRX
0.536%
Bio-Rad Laboratories, Inc.
BIO
0.518%
Avantor, Inc.
AVTR
0.516%
Simulations Plus, Inc.
SLP
0.308%
Veracyte, Inc.
VCYT
0.212%
Dynavax Technologies Corporation
DVAX
0.195%
Alexandria Real Estate Equities, Inc.
ARE
0.153%